Výsledky vyhledávání

Akademický článek

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences.

Autor: Tabbò F; Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10043, Orbassano, TO, Italy. Electronic address: fabrizio.tabbo@unito.it., Muscarella LA; Laboratory of Oncology, Fondazione IRCCS Casa Sollievo Della Sofferenza Hospital, San Giovanni Rotondo, Foggia, Italy., Gobbini E; Cancer Research Center Lyon, Centre Léon Bérard, 28 Rue Laennec, 69373, Lyon, France; Thoracic Oncology Unit, CHU Grenoble, Avenue Maquis Du Grésivaudan, 38700, La Tronche, France., Trombetta D; Laboratory of Oncology, Fondazione IRCCS Casa Sollievo Della Sofferenza Hospital, San Giovanni Rotondo, Foggia, Italy., Castellana S; Bioinformatic Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza Hospital, San Giovanni Rotondo, Foggia, Italy., Rigutto A; Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10043, Orbassano, TO, Italy., Galetta D; Medical Thoracic Unit, IRCCS Istituto Tumori Giovanni Paolo II, Viale Orazio Flacco 65, 70124, Bari, Italy., Maiello E; Oncology Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza Hospital, Viale Cappuccini 1, 71013, San Giovanni Rotondo, Italy., Martelli O; Medical Oncology Unit, San Giovanni Addolorata Hospital, Via Dell'Amba Aradam 9, 00184, Rome, Italy., Tiseo M; Medical Oncology Unit, University Hospital, Via Gramsci 14, 43123, Parma, Italy; Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43123, Parma, Italy., Scotti V; Radiotherapy Unit, University Hospital Careggi, Largo Brambilla 3, 50134, Firenze, Italy., Ghilardi L; Oncology Department, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24127, Bergamo, Italy., Gregorc V; Department of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, San Raffaele Hospital, Via Olgettina Milano 60, 20132, Milano, Italy., Sergi C; Oncology Unit, A.O.R.N.A.S Garibaldi Nesima, Via Palermo 636, 95100, Catania, Italy., Pilotto S; Oncology Unit, Department of Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy., Del Conte A; Medical Oncology and Immuno-Related Tumors Unit, Centro di Riferimento Oncologico (CRO) IRCCS, Via Gallini 2, 33081, Aviano, Italy., Cappuzzo F; Istituto Nazionale Tumori IRCCS Regina Elena, Via E. Chianesi 53, 00144, Roma, Italy., Cortinovis D; Oncology Unit, ASST San Gerardo Hospital, Via G. B. Pergolesi 33, 20900 Monza, Italy., Osman G; UOSD Pneumologia Oncologica, San Camillo Forlanini Hospital, Circonvallazione Gianicolense 87, 00152, Roma, Italy., Bareggi C; Oncology Unit, IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy., Di Maio M; Department of Oncology, University of Turin, Mauriziano Hospital, Largo F. Turati 62, 10128, Torino, Italy., Rossi A; Oncology Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza Hospital, Viale Cappuccini 1, 71013, San Giovanni Rotondo, Italy., Rossi G; Operative Unit of Pathologic Anatomy, Azienda Unità Sanitaria Locale Della Romagna, Hospital St. Maria Delle Croci, Viale V. Randi 5, 48121, Ravenna, Italy., Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo A. Gemelli 8, 00168, Roma, Italy; Section of Oncology, Department of Translational Medicine, Università Cattolica Del Sacro Cuore, Largo F. Vito 1, 00168, Roma, Italy., Volante M; Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10043, Orbassano, TO, Italy., Scagliotti GV; Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10043, Orbassano, TO, Italy., Graziano P; Pathology Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza Hospital, Viale Cappuccini 1, 71013, San Giovanni Rotondo, FG, Italy., Novello S; Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10043, Orbassano, TO, Italy., Righi L; Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10043, Orbassano, TO, Italy.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Oct; Vol. 174, pp. 200-211. Date of Electronic Publication: 2022 Aug 28.

Zobrazit plný text záznamu

Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness

Autor: Ribero S, Galli F, Osella-Abate S, Bertero L, Cattaneo L, Merelli B, Tondini C, Ghilardi L, De Giorgi V, Occelli M, Quaglino P, Cassoni P, Palmieri G, Massi D, Mandala M on behalf of the Italian Melanoma Intergroup (IMI).

Publikováno v: Journal of the American Academy of Dermatology (Online) (2018).
info:cnr-pdr/source/autori:Ribero S, Galli F, Osella-Abate S, Bertero L, Cattaneo L, Merelli B, Tondini C, Ghilardi L, De Giorgi V, Occelli M, Quaglino P, Cassoni P, Palmieri G, Massi D, Mandala M on behalf of the Italian Melanoma Intergroup (IMI)./titolo:Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness/doi:/rivista:Journal of the American Academy of Dermatology (Online)/anno:2018/pagina_da:/pagina_a:/intervallo_pagine:/volume

Background: The impact of histologic regression on sentinel lymph node biopsy (SLNB) status and on clinical outcome is uncertain. Objective: To investigate whether and to what extent regression \75% is able to predict SLNB status and clinical outcome

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::46aee733f06f80e4f4c6a732f4e26d2f
https://publications.cnr.it/doc/392459

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání